Sort   by:  
 Page size 
UnknownPrognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma.
Not available
S-EPMC6773637 | biostudies-literature
UnknownFactors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Not available
S-EPMC7705592 | biostudies-literature
UnknownSurgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making.
Not available
S-EPMC8989932 | biostudies-literature
UnknownCA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Not available
S-EPMC9726670 | biostudies-literature
UnknownFutility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer.
Not available
S-EPMC11270270 | biostudies-literature
UnknownRole of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression.
Not available
S-EPMC10280811 | biostudies-literature
UnknownSame-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE).
Not available
S-EPMC10901646 | biostudies-literature
UnknownEx-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy.
Not available
S-EPMC9307734 | biostudies-literature
UnknownPro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer.
Not available
S-EPMC10542011 | biostudies-literature
UnknownPrediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach.
Not available
S-EPMC8508250 | biostudies-literature
Sort   by:  
 Page size